81 related articles for article (PubMed ID: 22476976)
21. Quality of life, depression and fatigue in mildly disabled patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon beta-1a: 3-year results from the COGIMUS (COGnitive Impairment in MUltiple Sclerosis) study.
Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Picconi O; Cilia S; Cottone S; Centonze D; Gasperini C;
Mult Scler; 2011 Aug; 17(8):991-1001. PubMed ID: 21502310
[TBL] [Abstract][Full Text] [Related]
22. [Disseminated sclerosis: organic basis for mental disorders and cognitive dysfunction].
Stenager E; Knudsen L; Jensen K
Nord Med; 1991; 106(2):43-4, 49. PubMed ID: 2006091
[TBL] [Abstract][Full Text] [Related]
23. Clinical-radiologic heterogeneity of occipital neuralgiform pain as multiple sclerosis relapse.
De Santi L; Monti L; Menci E; Bellini M; Annunziata P
Headache; 2009 Feb; 49(2):304-7. PubMed ID: 18647183
[TBL] [Abstract][Full Text] [Related]
24. A short version of Rao's Brief Repeatable Battery as a screening tool for cognitive impairment in multiple sclerosis.
Portaccio E; Goretti B; Zipoli V; Siracusa G; Sorbi S; Amato MP
Clin Neuropsychol; 2009 Feb; 23(2):268-75. PubMed ID: 18609336
[TBL] [Abstract][Full Text] [Related]
25. Social cognition impairments in relapsing-remitting multiple sclerosis.
Henry A; Tourbah A; Chaunu MP; Rumbach L; Montreuil M; Bakchine S
J Int Neuropsychol Soc; 2011 Nov; 17(6):1122-31. PubMed ID: 22014035
[TBL] [Abstract][Full Text] [Related]
26. Cognitive compensation failure in multiple sclerosis.
Bonnet MC; Allard M; Dilharreguy B; Deloire M; Petry KG; Brochet B
Neurology; 2010 Oct; 75(14):1241-8. PubMed ID: 20921510
[TBL] [Abstract][Full Text] [Related]
27. [Cognitive evoked potentials in remitting-relapsing and benign forms of multiple sclerosis].
Vázquez-Marrufo M; González-Rosa J; Vaquero-Casares E; Duque P; Borges M; Izquierdo G
Rev Neurol; 2009 May 1-15; 48(9):453-8. PubMed ID: 19396761
[TBL] [Abstract][Full Text] [Related]
28. Progressive multifocal leukoencephalopathy and relapsing-remitting multiple sclerosis: a comparative study.
Boster A; Hreha S; Berger JR; Bao F; Penmesta R; Tselis A; Endress C; Zak I; Perumal J; Caon C; Vazquez J; Tyler KL; Racke MK; Millis S; Khan O
Arch Neurol; 2009 May; 66(5):593-9. PubMed ID: 19433659
[TBL] [Abstract][Full Text] [Related]
29. Multiple white matter tract abnormalities underlie cognitive impairment in RRMS.
Yu HJ; Christodoulou C; Bhise V; Greenblatt D; Patel Y; Serafin D; Maletic-Savatic M; Krupp LB; Wagshul ME
Neuroimage; 2012 Feb; 59(4):3713-22. PubMed ID: 22062194
[TBL] [Abstract][Full Text] [Related]
30. Cognitive impairment in relation to MRI metrics in patients with clinically isolated syndrome.
Khalil M; Enzinger C; Langkammer C; Petrovic K; Loitfelder M; Tscherner M; Jehna M; Bachmaier G; Wallner-Blazek M; Ropele S; Schmidt R; Fuchs S; Fazekas F
Mult Scler; 2011 Feb; 17(2):173-80. PubMed ID: 20956399
[TBL] [Abstract][Full Text] [Related]
31. Cognitive impairments in relapsing-remitting multiple sclerosis: a meta-analysis.
Prakash RS; Snook EM; Lewis JM; Motl RW; Kramer AF
Mult Scler; 2008 Nov; 14(9):1250-61. PubMed ID: 18701571
[TBL] [Abstract][Full Text] [Related]
32. Multiple sclerosis coexisting with spinal cord ependymoma: a case report.
Degirmenci E
Ideggyogy Sz; 2012 Sep; 65(9-10):342-4. PubMed ID: 23126220
[TBL] [Abstract][Full Text] [Related]
33. Structural changes of the corpus callosum in mild cognitive impairment and Alzheimer's disease.
Thomann PA; Wustenberg T; Pantel J; Essig M; Schroder J
Dement Geriatr Cogn Disord; 2006; 21(4):215-20. PubMed ID: 16415572
[TBL] [Abstract][Full Text] [Related]
34. Corpus callosum function in verbal dichotic listening: inferences from a longitudinal follow-up of Relapsing-Remitting Multiple Sclerosis patients.
Gadea M; Marti-Bonmatí L; Arana E; Espert R; Salvador A; Casanova B
Brain Lang; 2009 Aug; 110(2):101-5. PubMed ID: 19419759
[TBL] [Abstract][Full Text] [Related]
35. Cognitive and brain imaging measures of multiple sclerosis.
Pozzilli C; Passafiume D; Anzini A; Borsellino G; Koudriavsteva T; Sarlo G; Fieschi C
Ital J Neurol Sci; 1992 Dec; 13(9 Suppl 14):133-6. PubMed ID: 1345734
[TBL] [Abstract][Full Text] [Related]
36. Cognitive function in relapsing multiple sclerosis: minimal changes in a 10-year clinical trial.
Schwid SR; Goodman AD; Weinstein A; McDermott MP; Johnson KP;
J Neurol Sci; 2007 Apr; 255(1-2):57-63. PubMed ID: 17331542
[TBL] [Abstract][Full Text] [Related]
37. Symptom cluster and physical activity in relapsing-remitting multiple sclerosis.
Motl RW; Weikert M; Suh Y; Dlugonski D
Res Nurs Health; 2010 Oct; 33(5):398-412. PubMed ID: 20725947
[TBL] [Abstract][Full Text] [Related]
38. Atrophy of the corpus callosum, cognitive impairment, and cortical hypometabolism in progressive supranuclear palsy.
Yamauchi H; Fukuyama H; Nagahama Y; Katsumi Y; Dong Y; Konishi J; Kimura J
Ann Neurol; 1997 May; 41(5):606-14. PubMed ID: 9153522
[TBL] [Abstract][Full Text] [Related]
39. Shape analysis of the corpus callosum and cerebellum in female MS patients with different clinical phenotypes.
Sigirli D; Ercan I; Ozdemir ST; Taskapilioglu O; Hakyemez B; Turan OF
Anat Rec (Hoboken); 2012 Jul; 295(7):1202-11. PubMed ID: 22585536
[TBL] [Abstract][Full Text] [Related]
40. APOE-epsilon4 is not associated with cognitive impairment in relapsing-remitting multiple sclerosis.
Portaccio E; Goretti B; Zipoli V; Nacmias B; Stromillo ML; Bartolozzi ML; Siracusa G; Guidi L; Federico A; Sorbi S; De Stefano N; Amato MP
Mult Scler; 2009 Dec; 15(12):1489-94. PubMed ID: 19965518
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
